Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-04 | 2024-09 | -0.03 | N/A | N/A | N/A |
2024-08-05 | 2024-06 | -0.04 | 0.01 | 0.05 | 125.00% |
2024-05-07 | 2024-03 | -0.07 | N/A | N/A | N/A |
2024-05-07 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-03-12 | 2023-12 | -0.18 | N/A | N/A | N/A |
2024-03-12 | 2023-12 | -0.18 | -0.12 | 0.06 | 33.33% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-10 | Citigroup | Upgrade | Neutral | Neutral |
2023-03-05 | Canaccord Genuity | Upgrade | Buy | |
2023-03-05 | Credit Suisse | Upgrade | Underperform | |
2022-11-15 | Citigroup | Upgrade | Neutral | |
2022-11-07 | SVB Leerink | Upgrade | Market Perform | |
2022-08-08 | Citigroup | Upgrade | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-01-02 | CLINTON CHELSEA | Director | 541.84K | Stock Award(Grant) |
2024-01-02 | EDWARDS CARLADENISE ARMBRISTER | Director | 412.25K | Stock Award(Grant) |
2024-08-08 | GARIPALLI VIVEK | Director and Beneficial Owner of more than 10% of a Class of Security | 1.41M | Purchase |
2024-01-02 | KOUZOUKAS DEMETRIOS L | Director | 465.64K | Stock Award(Grant) |
2024-05-16 | LOENGARD ANNA U | Director | 0.00 | Purchase |
2024-09-12 | REYNOSO JAMIE L. | Officer | 2.75M | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 31.43M | 28.20M | 7.92% |
2023-06-29 | Renaissance Technologies, LLC | 8.85M | 7.94M | 2.23% |
2023-06-29 | Blackrock Inc. | 7.77M | 6.97M | 1.96% |
2023-06-29 | Citadel Advisors Llc | 5.35M | 4.80M | 1.35% |
2023-06-29 | PNC Financial Services Group, Inc. | 5.26M | 4.72M | 1.33% |
2023-06-29 | Millennium Management Llc | 4.65M | 4.17M | 1.17% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.28M | 9.22M | 2.59% |
2023-06-29 | Vanguard Small-Cap Index Fund | 9.15M | 8.21M | 2.30% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 5.24M | 4.70M | 1.32% |
2023-06-29 | Vanguard Extended Market Index Fund | 4.77M | 4.28M | 1.20% |
2023-05-30 | Fidelity Extended Market Index Fund | 1.70M | 1.44M | 0.43% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 1.37M | 1.16M | 0.34% |
-
So 11:15 means tomorrow? Why keep such important red away from us?
-
1595 to register to watch this damn thing!
-
Anything getting this much action right now should be up. What the fuc manipulation is this?
-
Let’s stonk it
-
I think we would all win if chartmill stopped posting on everything. I hate that thing and it is shit anyway just stop
-
Did Chamath plan for this?!!
chamath teaming with WSB to destroy shorts via $GME.
In return to make $CLOV trending with WAB’s help?? Hmmmmm... -
Stop selling
-
What is wrong with this one
-
13.20 again coming
-
Well well well..
-
Lol back to 11
-
Broke 14.25 and we go to moon
-
Come 2 13 again am there
-
Let’s gooooooooo
-
Last max pain day to burn the options then we fly next week🪰
-
Today it will be the same red day to fudge the options then skyrocket AH.
-
Pick up me in 13.80
-
I’m confident it will pop, it needs some time. Look at GIK it went up after a month of being flat.
-
Soon 50
-
this is a POS
-
Clover Health Investments (NASDAQ:CLOV) Stock Price Up 6.4%
news.google.com • -
Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference
globenewswire.com • -
CLOV Stock Alert: What to Know About Clover Health's Big Insider Buy
investorplace.com • -
3 Healthcare AI Stocks Positioned for Potential Breakthroughs
investorplace.com • -
Clover Health Investments, Corp. (CLOV) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
Clover Health to Report Second Quarter 2024 Financial Results on August 5
globenewswire.com • -
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement
globenewswire.com • -
The 'Undercovered' Dozen From June 1-6
seekingalpha.com • -
Clover Health: New Business Model Is A Game Changer
seekingalpha.com •